Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, RVMD, NBIX, ALNY, and represent 31.64% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: RNA (+$94M), RVMD (+$46M), VRTX (+$25M), AKRO (+$19M), IMCR (+$13M), SRRK (+$11M), UNH (+$9.6M), THC (+$8.2M), ELV (+$7.4M), HUM (+$7.1M).
- Started 17 new stock positions in RNA, ICLR, GMAB, AMRX, RPRX, THC, ADPT, ALKS, META, AVTR. BKD, VKTX, UTHR, AAPL, SNY, CORT, GH.
- Reduced shares in these 10 stocks: IONS (-$105M), ALNY (-$105M), BPMC (-$37M), MRNA (-$32M), SYK (-$31M), ARGX (-$18M), MDT (-$15M), HCA (-$14M), ISRG (-$14M), ABT (-$11M).
- Sold out of its positions in ADMA, ACLX, ARQT, BRBR, BDTX, BPMC, MTSR, NVO, TVTX, VRNA. OCS.
- Bellevue Group was a net seller of stock by $-232M.
- Bellevue Group has $4.8B in assets under management (AUM), dropping by 6.08%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bellevue Group
Bellevue Group holds 148 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 8.5 | $409M | -20% | 6.2M | 65.42 |
|
| Argenx Se Sponsored Adr (ARGX) | 8.4 | $403M | -4% | 546k | 737.56 |
|
| Revolution Medicines (RVMD) | 5.4 | $260M | +21% | 5.6M | 46.70 |
|
| Neurocrine Biosciences (NBIX) | 5.1 | $248M | -3% | 1.8M | 140.38 |
|
| Alnylam Pharmaceuticals (ALNY) | 4.2 | $204M | -33% | 447k | 456.00 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.1 | $198M | +14% | 506k | 391.64 |
|
| Abbott Laboratories (ABT) | 4.1 | $198M | -5% | 1.5M | 133.94 |
|
| Stryker Corporation (SYK) | 3.5 | $167M | -15% | 451k | 369.67 |
|
| Boston Scientific Corporation (BSX) | 3.4 | $162M | -5% | 1.7M | 97.63 |
|
| Intuitive Surgical Com New (ISRG) | 3.2 | $156M | -7% | 349k | 447.23 |
|
| Agios Pharmaceuticals (AGIO) | 3.1 | $149M | +3% | 3.7M | 40.14 |
|
| Incyte Corporation (INCY) | 2.5 | $122M | -8% | 1.4M | 84.81 |
|
| Scholar Rock Hldg Corp (SRRK) | 2.5 | $121M | +10% | 3.2M | 37.24 |
|
| Akero Therapeutics (AKRO) | 2.4 | $113M | +20% | 2.4M | 47.48 |
|
| Immunocore Hldgs Ads (IMCR) | 2.1 | $102M | +14% | 2.8M | 36.33 |
|
| Avidity Biosciences Ord (RNA) | 1.9 | $94M | NEW | 2.2M | 43.57 |
|
| Celldex Therapeutics Com New (CLDX) | 1.9 | $92M | +7% | 3.6M | 25.87 |
|
| Medtronic SHS (MDT) | 1.5 | $72M | -17% | 760k | 95.24 |
|
| Beam Therapeutics (BEAM) | 1.5 | $70M | 2.9M | 24.27 |
|
|
| Edwards Lifesciences (EW) | 1.4 | $70M | 897k | 77.77 |
|
|
| Insulet Corporation (PODD) | 1.4 | $66M | -3% | 212k | 308.73 |
|
| UnitedHealth (UNH) | 1.2 | $59M | +19% | 170k | 345.30 |
|
| Becton, Dickinson and (BDX) | 1.2 | $56M | -6% | 297k | 187.17 |
|
| Dex (DXCM) | 1.1 | $53M | -8% | 786k | 67.29 |
|
| Thermo Fisher Scientific (TMO) | 1.1 | $52M | -6% | 106k | 485.02 |
|
| IDEXX Laboratories (IDXX) | 1.0 | $49M | 77k | 638.89 |
|
|
| ResMed (RMD) | 0.9 | $45M | 165k | 273.73 |
|
|
| Edgewise Therapeutics (EWTX) | 0.9 | $45M | 2.8M | 16.22 |
|
|
| Relay Therapeutics (RLAY) | 0.9 | $44M | 8.3M | 5.22 |
|
|
| Biohaven (BHVN) | 0.9 | $42M | 2.8M | 15.01 |
|
|
| Abbvie (ABBV) | 0.8 | $40M | +7% | 171k | 231.54 |
|
| Penumbra (PEN) | 0.8 | $37M | -15% | 147k | 253.32 |
|
| Cigna Corp (CI) | 0.7 | $35M | +10% | 123k | 288.25 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.7 | $35M | -10% | 463k | 75.10 |
|
| Anthem (ELV) | 0.7 | $34M | +27% | 105k | 323.12 |
|
| Danaher Corporation (DHR) | 0.7 | $33M | +19% | 164k | 198.26 |
|
| Eli Lilly & Co. (LLY) | 0.6 | $31M | 41k | 763.00 |
|
|
| Wave Life Sciences SHS (WVE) | 0.6 | $30M | 4.1M | 7.32 |
|
|
| McKesson Corporation (MCK) | 0.6 | $29M | -6% | 38k | 772.54 |
|
| Steris Shs Usd (STE) | 0.6 | $29M | +7% | 118k | 247.44 |
|
| Veeva Sys Cl A Com (VEEV) | 0.6 | $29M | -13% | 98k | 297.91 |
|
| Hca Holdings (HCA) | 0.6 | $28M | -33% | 66k | 426.20 |
|
| Zimmer Holdings (ZBH) | 0.5 | $24M | -8% | 245k | 98.50 |
|
| Cooper Cos (COO) | 0.4 | $20M | -17% | 292k | 68.56 |
|
| Humana (HUM) | 0.4 | $20M | +55% | 76k | 260.17 |
|
| Globus Med Cl A (GMED) | 0.4 | $19M | 327k | 57.27 |
|
|
| Align Technology (ALGN) | 0.4 | $18M | -4% | 145k | 125.22 |
|
| Molina Healthcare (MOH) | 0.4 | $17M | +22% | 91k | 191.36 |
|
| Hologic (HOLX) | 0.3 | $17M | 248k | 67.49 |
|
|
| Macrogenics (MGNX) | 0.3 | $17M | 9.9M | 1.68 |
|
|
| Privia Health Group (PRVA) | 0.3 | $17M | +5% | 666k | 24.90 |
|
| Procept Biorobotics Corp (PRCT) | 0.3 | $17M | -5% | 463k | 35.69 |
|
| Annexon (ANNX) | 0.3 | $16M | 5.2M | 3.05 |
|
|
| Encompass Health Corp (EHC) | 0.3 | $16M | -6% | 123k | 127.02 |
|
| Natera (NTRA) | 0.3 | $15M | -37% | 92k | 160.97 |
|
| Masimo Corporation (MASI) | 0.3 | $14M | +8% | 97k | 147.55 |
|
| Johnson & Johnson (JNJ) | 0.3 | $14M | +9% | 75k | 185.42 |
|
| EXACT Sciences Corporation (EXAS) | 0.3 | $14M | -11% | 253k | 54.71 |
|
| Transmedics Group (TMDX) | 0.3 | $13M | -10% | 117k | 112.20 |
|
| Beone Medicines Sponsored Ads (ONC) | 0.2 | $12M | -12% | 34k | 340.70 |
|
| Centene Corporation (CNC) | 0.2 | $10M | +102% | 282k | 35.68 |
|
| Iqvia Holdings (IQV) | 0.2 | $10M | +56% | 53k | 189.94 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $8.8M | -9% | 316k | 28.00 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.2 | $8.6M | 424k | 20.20 |
|
|
| Regeneron Pharmaceuticals (REGN) | 0.2 | $8.5M | -43% | 15k | 562.27 |
|
| Caredx (CDNA) | 0.2 | $8.3M | -23% | 573k | 14.54 |
|
| Tenet Healthcare Corp Com New (THC) | 0.2 | $8.2M | NEW | 40k | 203.04 |
|
| Phreesia (PHR) | 0.2 | $7.4M | -5% | 313k | 23.52 |
|
| Axsome Therapeutics (AXSM) | 0.1 | $6.4M | -6% | 52k | 121.45 |
|
| Quest Diagnostics Incorporated (DGX) | 0.1 | $6.3M | -32% | 33k | 190.58 |
|
| Brightspring Health Svcs (BTSG) | 0.1 | $5.6M | 191k | 29.56 |
|
|
| Omada Health (OMDA) | 0.1 | $5.6M | 252k | 22.11 |
|
|
| Gilead Sciences (GILD) | 0.1 | $5.5M | -2% | 50k | 111.00 |
|
| BioMarin Pharmaceutical (BMRN) | 0.1 | $5.5M | -33% | 101k | 54.16 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $5.0M | -13% | 25k | 198.81 |
|
| Waystar Holding Corp (WAY) | 0.1 | $4.9M | -13% | 130k | 37.92 |
|
| Glaukos (GKOS) | 0.1 | $4.6M | 56k | 81.55 |
|
|
| Si-bone (SIBN) | 0.1 | $4.4M | -44% | 299k | 14.72 |
|
| Inspire Med Sys (INSP) | 0.1 | $4.4M | -22% | 59k | 74.20 |
|
| Labcorp Holdings Com Shs (LH) | 0.1 | $4.3M | -58% | 15k | 287.06 |
|
| Icon SHS (ICLR) | 0.1 | $4.2M | NEW | 24k | 175.00 |
|
| Amgen (AMGN) | 0.1 | $4.2M | -37% | 15k | 282.20 |
|
| CVS Caremark Corporation (CVS) | 0.1 | $3.9M | +70% | 51k | 75.39 |
|
| 10x Genomics Cl A Com (TXG) | 0.1 | $3.7M | -3% | 314k | 11.69 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $3.3M | -3% | 34k | 98.62 |
|
| Kestra Med Technologies SHS (KMTS) | 0.1 | $3.1M | -3% | 129k | 23.76 |
|
| Insmed Com Par $.01 (INSM) | 0.1 | $2.9M | -75% | 20k | 144.01 |
|
| Merck & Co (MRK) | 0.1 | $2.9M | +23% | 35k | 83.93 |
|
| Neogenomics Com New (NEO) | 0.1 | $2.9M | -59% | 370k | 7.72 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $2.8M | 85k | 32.61 |
|
|
| Astrazeneca Sponsored Adr (AZN) | 0.1 | $2.7M | -7% | 36k | 76.72 |
|
| Cardinal Health (CAH) | 0.1 | $2.6M | -18% | 16k | 156.96 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.1 | $2.5M | NEW | 169k | 14.96 |
|
| Illumina (ILMN) | 0.0 | $2.3M | -13% | 24k | 94.97 |
|
| Bristol Myers Squibb (BMY) | 0.0 | $2.1M | +28% | 48k | 45.10 |
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.0 | $2.1M | 3.1k | 666.18 |
|
|
| Viking Therapeutics (VKTX) | 0.0 | $2.0M | NEW | 76k | 26.28 |
|
| Baxter International (BAX) | 0.0 | $1.6M | -55% | 68k | 22.77 |
|
| AmerisourceBergen (COR) | 0.0 | $1.5M | -39% | 4.9k | 312.53 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $1.4M | -29% | 19k | 76.40 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $1.4M | +5% | 21k | 66.43 |
|
| Avantor (AVTR) | 0.0 | $1.3M | NEW | 103k | 12.48 |
|
| Beta Bionics (BBNX) | 0.0 | $1.3M | -3% | 64k | 19.87 |
|
| United Therapeutics Corporation (UTHR) | 0.0 | $1.1M | NEW | 2.6k | 419.21 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $1.1M | +117% | 2.4k | 458.66 |
|
| Bridgebio Pharma (BBIO) | 0.0 | $1.1M | +95% | 20k | 51.94 |
|
| Mineralys Therapeutics (MLYS) | 0.0 | $1.0M | +71% | 27k | 37.92 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.0 | $914k | -56% | 9.1k | 100.99 |
|
| Brookdale Senior Living (BKD) | 0.0 | $887k | NEW | 105k | 8.47 |
|
| Certara Ord (CERT) | 0.0 | $726k | -27% | 59k | 12.22 |
|
| Doximity Cl A (DOCS) | 0.0 | $709k | -59% | 9.7k | 73.15 |
|
| Biogen Idec (BIIB) | 0.0 | $590k | +948% | 4.2k | 140.08 |
|
| Ishares Tr Russell 2000 Etf (IWM) | 0.0 | $557k | 2.3k | 241.96 |
|
|
| Garmin SHS (GRMN) | 0.0 | $500k | +138% | 2.0k | 246.22 |
|
| Royalty Pharma Shs Class A (RPRX) | 0.0 | $457k | NEW | 13k | 35.28 |
|
| Planet Fitness Cl A (PLNT) | 0.0 | $446k | +59% | 4.3k | 103.80 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.0 | $418k | NEW | 8.9k | 47.20 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $416k | -28% | 15k | 28.44 |
|
| Apple (AAPL) | 0.0 | $410k | NEW | 1.6k | 254.63 |
|
| Tempus Ai Cl A (TEM) | 0.0 | $405k | +2015% | 5.0k | 80.71 |
|
| Amazon (AMZN) | 0.0 | $398k | +57% | 1.8k | 219.57 |
|
| Summit Therapeutics (SMMT) | 0.0 | $392k | -54% | 19k | 20.66 |
|
| Exelixis (EXEL) | 0.0 | $304k | -13% | 7.4k | 41.30 |
|
| Pfizer (PFE) | 0.0 | $301k | -83% | 12k | 25.48 |
|
| Meta Platforms Cl A (META) | 0.0 | $294k | NEW | 400.00 | 734.38 |
|
| Caris Life Sciences (CAI) | 0.0 | $291k | -3% | 9.6k | 30.25 |
|
| Uniqure Nv SHS (QURE) | 0.0 | $278k | -75% | 4.8k | 58.37 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.0 | $264k | 2.0k | 131.77 |
|
|
| Alphabet Cap Stk Cl A (GOOGL) | 0.0 | $263k | -25% | 1.1k | 243.10 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $251k | +1068% | 35k | 7.17 |
|
| Moderna (MRNA) | 0.0 | $241k | -99% | 9.3k | 25.83 |
|
| Krystal Biotech (KRYS) | 0.0 | $232k | +4% | 1.3k | 176.53 |
|
| Alkermes SHS (ALKS) | 0.0 | $198k | NEW | 6.6k | 30.00 |
|
| Ptc Therapeutics I (PTCT) | 0.0 | $155k | -33% | 2.5k | 61.37 |
|
| NVIDIA Corporation (NVDA) | 0.0 | $131k | -6% | 702.00 | 186.58 |
|
| Zoetis Cl A (ZTS) | 0.0 | $128k | +32% | 872.00 | 146.32 |
|
| Guardant Health (GH) | 0.0 | $122k | NEW | 2.0k | 62.48 |
|
| Oracle Corporation (ORCL) | 0.0 | $117k | -36% | 417.00 | 281.24 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $115k | -43% | 2.1k | 54.96 |
|
| Microsoft Corporation (MSFT) | 0.0 | $105k | 203.00 | 517.95 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $104k | 806.00 | 128.35 |
|
|
| Corcept Therapeutics Incorporated (CORT) | 0.0 | $102k | NEW | 1.2k | 83.11 |
|
| Genmab A/s Sponsored Ads (GMAB) | 0.0 | $92k | NEW | 3.0k | 30.67 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $79k | NEW | 7.9k | 10.01 |
|
| Merus N V (MRUS) | 0.0 | $78k | -89% | 825.00 | 94.15 |
|
| Qualcomm (QCOM) | 0.0 | $74k | 447.00 | 166.36 |
|
|
| Mettler-Toledo International (MTD) | 0.0 | $52k | 42.00 | 1227.62 |
|
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $27k | 5.5k | 4.88 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2025 Q3 filed Nov. 14, 2025
- Bellevue Group 2025 Q2 filed Aug. 14, 2025
- Bellevue Group 2025 Q1 filed May 14, 2025
- Bellevue Group 2024 Q4 filed Feb. 14, 2025
- Bellevue Group 2024 Q3 filed Nov. 14, 2024
- Bellevue Group 2024 Q2 filed Aug. 14, 2024
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022